171 related articles for article (PubMed ID: 34435232)
1. Long-term expression changes of immune-related genes in prostate cancer after radiotherapy.
Eke I; Aryankalayil MJ; Bylicky MA; Sandfort V; Vanpouille-Box C; Nandagopal S; Graves EE; Giaccia AJ; Coleman CN
Cancer Immunol Immunother; 2022 Apr; 71(4):839-850. PubMed ID: 34435232
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner.
Eke I; Aryankalayil MJ; Bylicky MA; Makinde AY; Liotta L; Calvert V; Petricoin EF; Graves EE; Coleman CN
Sci Rep; 2022 Mar; 12(1):3500. PubMed ID: 35241721
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
[TBL] [Abstract][Full Text] [Related]
4. Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.
Aryankalayil MJ; Makinde AY; Gameiro SR; Hodge JW; Rivera-Solis PP; Palayoor ST; Ahmed MM; Coleman CN
Radiat Res; 2014 Aug; 182(2):139-48. PubMed ID: 25003313
[TBL] [Abstract][Full Text] [Related]
5. mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.
Simone CB; John-Aryankalayil M; Palayoor ST; Makinde AY; Cerna D; Falduto MT; Magnuson SR; Coleman CN
Transl Oncol; 2013; 6(5):573-85. PubMed ID: 24151538
[TBL] [Abstract][Full Text] [Related]
6. Fractionated radiation therapy can induce a molecular profile for therapeutic targeting.
John-Aryankalayil M; Palayoor ST; Cerna D; Simone CB; Falduto MT; Magnuson SR; Coleman CN
Radiat Res; 2010 Oct; 174(4):446-58. PubMed ID: 20726711
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of apoptosis related genes and radio-sensitivity of prostate cancer cells.
He Z; Zhang Y; Mehta SK; Pierson DL; Wu H; Rohde LH
J Radiat Res; 2011; 52(6):743-51. PubMed ID: 22020081
[TBL] [Abstract][Full Text] [Related]
8. Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer.
Eke I; Makinde AY; Aryankalayil MJ; Reedy JL; Citrin DE; Chopra S; Ahmed MM; Coleman CN
Mol Cancer Res; 2018 Dec; 16(12):1855-1864. PubMed ID: 30042176
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions.
Bernstein MB; Garnett CT; Zhang H; Velcich A; Wattenberg MM; Gameiro SR; Kalnicki S; Hodge JW; Guha C
Cancer Biother Radiopharm; 2014 May; 29(4):153-61. PubMed ID: 24693958
[TBL] [Abstract][Full Text] [Related]
10. Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
Holzapfel K; Müller SA; Seidl C; Grosu AL; Schwaiger M; Senekowitsch-Schmidtke R
Strahlenther Onkol; 2008 Jun; 184(6):319-24. PubMed ID: 18535808
[TBL] [Abstract][Full Text] [Related]
11. Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study.
Suetens A; Moreels M; Quintens R; Chiriotti S; Tabury K; Michaux A; Grégoire V; Baatout S
Int J Oncol; 2014 Apr; 44(4):1056-72. PubMed ID: 24504141
[TBL] [Abstract][Full Text] [Related]
12. The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation.
Rudner J; Ruiner CE; Handrick R; Eibl HJ; Belka C; Jendrossek V
Radiat Oncol; 2010 Nov; 5():108. PubMed ID: 21080918
[TBL] [Abstract][Full Text] [Related]
13. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
15. Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.
Wu X; Scott H; Carlsson SV; Sjoberg DD; Cerundolo L; Lilja H; Prevo R; Rieunier G; Macaulay V; Higgins GS; Verrill CL; Lamb AD; Cunliffe VT; Bountra C; Hamdy FC; Bryant RJ
Prostate; 2019 Jul; 79(10):1079-1089. PubMed ID: 31104332
[TBL] [Abstract][Full Text] [Related]
16. Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy.
Matthews Q; Jirasek A; Lum JJ; Brolo AG
Phys Med Biol; 2011 Nov; 56(21):6839-55. PubMed ID: 21971286
[TBL] [Abstract][Full Text] [Related]
17. High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta(1) integrin expression.
Simon EL; Goel HL; Teider N; Wang T; Languino LR; Fitzgerald TJ
Prostate; 2005 Jun; 64(1):83-91. PubMed ID: 15651037
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
19. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays.
Elgqvist J; Timmermand OV; Larsson E; Strand SE
Anticancer Res; 2016 Jan; 36(1):103-9. PubMed ID: 26722033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]